Literature DB >> 3201153

Surgery for synchronous hepatic metastases of colorectal cancer.

H Bismuth1, D Castaing, O Traynor.   

Abstract

Over the last 10 years 32 patients have had synchronous hepatic metastases from colorectal cancer treated surgically in this unit. As a general policy the metastases were resected 3-4 months after resection of the primary tumour. At the end of this interval a thorough assessment was made for recurrent local, regional or extrahepatic metastatic disease before making a decision to perform liver resection. Eighteen patients had a conventional liver resection (13 major liver resections, 5 limited liver resections) and 14 patients had an atypical liver resection (metastasectomy). Patients were followed at 4 monthly intervals after operation using ultrasonography and CEA determination. The operative mortality (within 60 days) was zero. Twenty-six patients (81%) had a totally uncomplicated postoperative course. The period of hospitalization was 14 +/- 2 days. Two patients had a second liver resection at a later date on account of tumour recurrence. The survival rates at 1, 2 and 3 years were 84%, 58% and 33% respectively. These results confirm that synchronous hepatic metastases from colorectal cancer can be resected with minimal morbidity and mortality and that worthwhile improvements in life expectancy result.

Entities:  

Mesh:

Year:  1988        PMID: 3201153     DOI: 10.3109/00365528809096972

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  20 in total

Review 1.  The surgical treatment of hepatic metastases in colorectal carcinoma.

Authors:  Ulf Peter Neumann; Daniel Seehofer; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2010-05-14       Impact factor: 5.594

2.  [Resection of liver metastases of colorectal tumors. A uni- and multivariate analysis of prognostic factors].

Authors:  J K Seifert; T Junginger
Journal:  Langenbecks Arch Chir       Date:  1996

3.  Role of a liver-first approach for synchronous colorectal liver metastases.

Authors:  Kun Wang; Wei Liu; Xiao-Luan Yan; Bao-Cai Xing
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

4.  Strategies for Management of Synchronous Colorectal Metastases.

Authors:  Jason A Castellanos; Nipun B Merchant
Journal:  Curr Surg Rep       Date:  2014-06-01

5.  Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Yoshirou Fujii; Itaru Endo; Hitoshi Sekido; Shinji Togo; Hideyuki Ike
Journal:  Langenbecks Arch Surg       Date:  2004-07-03       Impact factor: 3.445

6.  Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.

Authors:  H Bismuth; R Adam; F Lévi; C Farabos; F Waechter; D Castaing; P Majno; L Engerran
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

7.  Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations.

Authors:  Ioannis Vassiliou; Nick Arkadopoulos; Theodosios Theodosopoulos; Georgios Fragulidis; Athanasios Marinis; Agathi Kondi-Paphiti; Lazaros Samanides; Andreas Polydorou; Constantinos Gennatas; Dionysios Voros; Vassilios Smyrniotis
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

8.  Validity of observation interval for synchronous hepatic metastases of colorectal cancer: changes in hepatic and extrahepatic metastatic foci.

Authors:  Yasuhiro Shimizu; Kenzo Yasui; Tsuyoshi Sano; Takashi Hirai; Yukihide Kanemitsu; Koji Komori; Tomoyuki Kato
Journal:  Langenbecks Arch Surg       Date:  2008-01-04       Impact factor: 3.445

9.  Synchronous resection of colorectal primary cancer and liver metastases.

Authors:  Tristan D Yan; Francis Chu; Deborah Black; Denis W King; David L Morris
Journal:  World J Surg       Date:  2007-05-30       Impact factor: 3.352

Review 10.  Management of colorectal cancer presenting with synchronous liver metastases.

Authors:  Ajith K Siriwardena; James M Mason; Saifee Mullamitha; Helen C Hancock; Santhalingam Jegatheeswaran
Journal:  Nat Rev Clin Oncol       Date:  2014-06-03       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.